Novartis Pharmaceuticals UK Ltd
Sobre la empresa
Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world.
Dirección
Novartis Pharmaceuticals UK Limited
2nd Floor, The WestWorks Building, White City Place
195 Wood Lane, London, W12 7FQ
United Kingdom
Datos de contacto
Teléfono de información médica
44-1276-698370
Horario de atención
Mon-Fri 9am-5pm GMT (excl. bank holidays)
Correo electrónico de Información Médica
medinfo.uk@novartis.com
Efectos secundarios y reclamaciones de producto
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the information leaflet that comes in the pack.
You can report side effects via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ (UK). By reporting side effects, you can help provide more information on the safety of your medication.
Adverse events can also be reported to Novartis patient safety online through the patient safety information (PSI) tool at https://psi.novartis.com.
Comunicar un efecto adverso por teléfono
44-1276-698370
Comunicar un efecto adverso por correo electrónico
medinfo.uk@novartis.com
Company website
https://www.novartis.co.uk
Facebook
https://www.facebook.com/NovartisUK/
LinkedIn
https://www.linkedin.com/company/novartis-uk-limited/
Twitter
https://twitter.com/novartisuk
Novartis productos
Los medicamentos marcados con un▼están sujetos a un seguimiento adicional que permite la rápida identificación de nueva información de seguridad. Usted puede contribuir comunicando cualquier efecto secundario que conozca.
Afinitor®
(everolimus)
Aimovig® ▼
(erenumab)
Alomide®
(lodoxamide, trometamol)
Atectura Breezhaler®
(indacaterol, mometasone)
Azarga®
(brinzolamide, timolol )
Azopt®
(brinzolamide)
Beovu® ▼
(Brolucizumab)
Betoptic®
(betaxolol)
Certican®
(everolimus)
Ciloxan®
(ciprofloxacin)
Co-Diovan®
(valsartan, hydrochlorothiazide)
Cosentyx®
(secukinumab)
Desferal®
(desferrioxamine)
Diovan®
(valsartan)
DuoTrav®
(travoprost, timolol )
Enerzair Breezhaler®
(glycopyrronium, indacaterol, mometasone)
Entresto®
(sacubitril, valsartan)
Estradot®
(estradiol)
Eucreas®
(vildagliptin, metformin )
Exelon®
(rivastigmine)
Exforge®
(amlodipine, valsartan)
Exjade® ▼
(deferasirox)
Extavia®
(recombinant interferon beta-1b)
Fabhalta ▼
(iptacopan hydrochloride monohydrate)
Famvir®
(famciclovir)
Femara®
(letrozole)
Finlee®
(dabrafenib)
Galvus®
(vildagliptin)
Gilenya® ▼
(fingolimod)
Glivec® ▼
(imatinib)
Ilaris®
(canakinumab)
Jakavi®
(ruxolitinib)
Kesimpta® ▼
(ofatumumab)
Kisqali® ▼
(ribociclib)
Kymriah® ▼
(tisagenlecleucel)
Lamisil®
(terbinafine )
Leqvio® ▼
(inclisiran)
Lioresal®
(baclofen)
Lucentis®
(ranibizumab)
Luxturna® ▼
(Voretigene neparvovec)
Maxidex®
(dexamethasone)
Maxitrol®
(dexamethasone, polymyxin B, neomycin )
Mayzent® ▼
(Siponimod)
Mekinist®
(trametinib)
Moxivig®
(moxifloxacin)
Myfortic®
(mycophenolic acid as mycophenolate sodium)
Neoral®
(ciclosporin)
Nevanac®
(nepafenac)
Onbrez®
(indacaterol)
Opatanol®
(olopatadine)
Piqray® ▼
(alpelisib)
Prometax®
(rivastigmine)
Revolade®
(Eltrombopag)
Riamet®
(artemether, lumefantrine)
Rydapt® ▼
(midostaurin)
Sandimmun®
(ciclosporin)
Sandostatin®
(octreotide)
Sebivo®
(telbivudine)
Seebri®
(glycopyrronium)
Signifor®
(pasireotide)
Simbrinza®
(brinzolamide, brimonidine)
Simulect®
(basiliximab)
Spexotras®
(trametinib )
Tafinlar®
(dabrafenib)
Tasigna®
(nilotinib)
Tegretol®
(carbamazepine)
Tobradex®
(tobramycin, dexamethasone )
Transiderm-Nitro®
(nitroglycerin)
Travatan®
(travoprost)
Trileptal®
(oxcarbazepine)
Tyverb®
(lapatinib)
Ultibro®
(indacaterol, glycopyrronium )
Voltarol®
(diclofenac)
Votrient®
(pazopanib)
Votubia®
(everolimus)
Xolair®
(omalizumab)
Zofran®
(ondansetron)
Zykadia® ▼
(ceritinib)
